NuvOx Pharma
Evan Unger's work experience includes holding the position of President and CEO at NuvOx Pharma since 2008. Evan was also a Professor of Radiology and Biomedical Engineering at The University of Arizona Health Network from 1988 to 2018. Prior to that, they served as President and CEO at ImaRx Therapeutics from 2000 to 2006, and at ImaRx Pharmaceutical from 1990 to 1999.
Evan Unger began their education at the University of California, Berkeley, where they pursued a Bachelor's degree in Economics. Evan attended the university from 1972 to 1977. Following their undergraduate studies, Evan Unger went on to attend the University of California at San Francisco from 1978 to 1982. During this time, they obtained a Doctor of Medicine (MD) degree with a focus on Medicine.
This person is not in any teams
This person is not in any offices
NuvOx Pharma
NuvOx Pharma develops a platform for drugs that upon intravenous injection, flow through the bloodstream arriving first at the lungs to pick up oxygen and finally to hypoxic tissue where they passively deliver the oxygen. Indications for NuvOx's drug include Stroke (Phase II ready), Oncology (Phase II ready), and Sickle Cell Crisis (Phase Ibready).